Abstract #

Related by string. * abstract . abstracts . abstracted . Abstracts . abstracting : Abstract Free Full Text . STORED DOWNLOADED ABSTRACTED DISSEMINATED . abstract painting . abstract reasoning . Abstract Angus Reid / # [012] . # [007] . # [016] . #s [002] . # [014] : #.# ov #-# . ID # # . #-#:# pm [001] . i Newswire #-#-# . Call #-#-# [002] * ASH Abstract # . Abstract # LBA# . Abstract # TPS# *

Related by context. Frequent words. (Click for all words.) 71 Poster Session 64 J Clin Oncol 62 Pharmacokinetics 61 AACR NCI EORTC 59 Suppl 57 Am J Physiol 57 Molecular Targets 57 Ann Intern Med 57 #:#-# [023] 56 antitumor activity 55 ICAAC 55 suppl 55 Arch Intern Med 55 #:#-# [031] 55 metastatic renal cell carcinoma 55 ASCO Annual Meeting 55 Abstract Free Full Text 54 Tolerability 54 AASLD 54 dose escalation trial 54 Multiple Myeloma 53 #:#-# [028] 53 Crit Care Med 53 Biol 53 Free Full Text 52 INGN 52 Scientific Sessions 52 EASL 52 Efficacy 52 Clinical Oncology ASCO Annual 52 PMID # [002] 52 Arch Gen Psychiatry 52 #:#-# [022] 52 N Engl J 51 Bladder Cancer 51 #:#-# [029] 51 Antimicrobial Agents 51 Nutr 51 #:#-# [035] 51 Cardiol 51 CrossRef Medline 51 #:#-# [002] 51 Am J Clin 51 Article ChemPort 50 GSK # 50 Chemotherapy ICAAC 50 Article PubMed ChemPort 50 pharmacodynamic 50 J Psychiatry 50 J Am Coll 50 Preclinical 50 Joint Surg Am 50 AEZS 50 Annual Scientific Sessions 49 Hematology 49 #:#-# [033] 49 NSCLC 49 Angiogenesis 49 Article PubMed ISI ChemPort 49 Digestive Disease Week 49 #:#-# [037] 49 Scientific Session 49 Clinical Oncology 49 AACR Annual Meeting 49 Perifosine 48 ESMO 48 Liver Diseases 48 #:#-# [016] 48 HGS ETR1 48 Hematology ASH 48 #:#-# [006] 48 Phase 2a clinical 48 pharmacokinetic profile 48 Initiates Phase 48 solid tumors 48 GRN#L 48 Cell Lung Cancer 48 ASCO 48 Clinical Microbiology 48 hepatocellular carcinoma 48 :# [003] 48 League Against Rheumatism 48 ENMD 48 San Antonio Breast Cancer 48 refractory multiple myeloma 48 CUDC 48 EULAR 48 Phase Ib 48 AACR 47 castration resistant prostate cancer 47 Room #A 47 mg BID 47 Clinical Oncology ASCO 47 Metastatic 47 hepatocellular carcinoma HCC 47 resistant ovarian cancer 47 antiviral activity 47 CD# + [002] 47 Randomized 47 bortezomib 47 CYT#

Back to home page